[Oct. 22, 2023: Staff Writer, The Brighter Side of News] A pseudo-colored scanning electron micrograph of an oral squamous cancer cell (white) being attacked by two cytotoxic T cells (red)… Read More
Many organizations have come up with innovative ways to raise money for a cause they care about, but this one is by far the most creative idea.
A TikTok user named Macey Hall (@maceyphall) s… Read More
Regular use of chemical hair relaxers by Black women increased their risk of uterine cancer by 50%. (Boston University, Environmental Research)
Adding the immune activator BXCL701 to pembr… Read More
AssessYourRisk, a new online, cancer risk assessment and educational tool developed and offered by Dana-Farber Cancer Institute. The online tool uses a simple quiz to provide an individualiz… Read More
In the healthcare sector, a realm characterised by its resource-intensity and stringent compliance standards, the management of data is pivotal along every step of the clinical journey. Heal… Read More
The impact of immunotherapy, specifically immune checkpoint inhibitors, in advanced and metastatic cancer quickly led to interest in using the therapy in earlier-stage disease. Most recent… Read More
Image Source: www.psychreg.org
New Study Reveals Insights into Difficult-to-Treat Neuroendocrine Tumors
Neoadjuvant Immune Checkpoint Blockade Shows Promise in Cancer Treatment
In a groundb… Read More
The road to effective cancer vaccines has been long and difficult. Although initial attempts to use a vaccine to treat cancer date back to the 1910s, the first effective therapeutic vaccin… Read More
Presented by Humane Society Legislative Fund: Delivered daily, Influence gives you a comprehensive rundown and analysis of all lobby hires and news on K Street… Read More
Presented by the American Cancer Society Cancer Action Network: Delivered daily, Influence gives you a comprehensive rundown and analysis of all lobby hires and news on K Street… Read More
SINGAPORE — Extended pleurectomy/decortication combined with platinum and pemetrexed chemotherapy was associated with worse outcomes in patients with resectable mesothelioma compar… Read More
In a recent survey, almost a third of healthcare system pharmacists said drug shortages are “critically impacting” patient care. (CNN)
Six months of aerobic exercise helped red… Read More
A novel protein-degrading agent exhibited promising activity in patients with relapsed/refractory multiple myeloma, results of a preliminary clinical trial showed.
Among 101 patients who r… Read More
Bruce Springsteen and The E Street Band returned to Gillette Stadium in Foxborough, Massachusetts, on Thursday night for the first time since 2016. The show was a marathon affair, lasting ov… Read More
Phil Durst recalled clawing at his face after a chemical from a commercial dishwashing machine squirted into his eyes, causing “the most indescribable pain I’ve ever felt &mdas… Read More
Artificial Intelligence (AI) is steadily revolutionizing various aspects of human life, including the engagement with diseases such as cancer. Scientists and researchers are continuously emp… Read More
While there’s been a lot of scary news around AI—from robots replacing our jobs to potentially killing us all in Terminator-esque apocalypse scenarios—there are also more h… Read More
In this video, Paolo Tarantino, MD, of the Dana-Farber Cancer Institute in Boston, provides an overview of key updates in breast cancer from the recent American Society of Clinical Oncolog… Read More
— Award Candidates and Winners to be Presented on October 26, 2023, at the Prix Galien USA Forum in New York City
NEW YORK, July 27, 2023 /PRNewswire/ — The Galien Founda… Read More
With the pandemic acting as an accelerant, the healthcare industry is embracing AI enthusiastically. According to a 2020 survey by Optum, 80% of healthcare organizations have an AI strategy… Read More
According to the findings of the international, phase II DESTINY-PanTumor02 study, trastuzumab deruxtecan (T-DXd; Enhertu) was an effective treatment option for people with difficult-to-tr… Read More
Among patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), early phase II trial data that was presented at the American Society of Clinical Oncology (ASCO) annual m… Read More
Treatment with the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (axi-cel; Yescarta) resulted in significantly improved overall survival compared with the current… Read More
In the DREAMM-3 trial, belantamab mafodotin (belamaf; Blenrep) did not improve progression-free survival (PFS) in patients with relapsed/refractory multiple myeloma when compared with poma… Read More